相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter
Yang Mai et al.
MOLECULAR PHARMACEUTICS (2021)
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio
Leandro Francisco Pippa et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Advanced delivery strategies facilitating oral absorption of heparins
Guihua Fang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis
Holm Eggemann et al.
BRITISH JOURNAL OF CANCER (2020)
Sex differences in pharmacokinetics predict adverse drug reactions in women
Irving Zucker et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Gender medicine and oncology: report and consensus of an ESMO workshop
A. D. Wagner et al.
ANNALS OF ONCOLOGY (2019)
Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination
Esra Kaya Kilic et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2019)
Sex- and age-related changes in GABA signaling components in the human cortex
Madhavi Pandya et al.
BIOLOGY OF SEX DIFFERENCES (2019)
A Multiscale Physiologically-Based Pharmacokinetic Model for Doxorubicin to Explore its Mechanisms of Cytotoxicity and Cardiotoxicity in Human Physiological Contexts
Hua He et al.
PHARMACEUTICAL RESEARCH (2018)
Linezolid: a review of its properties, function, and use in critical care
Seyed MohammadReza Hashemian et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Sex differences in body composition and association with cardiometabolic risk
Melanie Schorr et al.
BIOLOGY OF SEX DIFFERENCES (2018)
Harnessing Meta-analysis to Refine an Oncology Patient Population for Physiology-Based Pharmacokinetic Modeling of Drugs
Emily Schwenger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
Seungwon Yang et al.
SCIENTIFIC REPORTS (2017)
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients
Yasuhiro Tsuji et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Population Pharmacokinetic Model of Cabozantinib in Patients with Medullary Thyroid Carcinoma and Its Application to an Exposure-Response Analysis
Dale Miles et al.
CLINICAL PHARMACOKINETICS (2016)
Clinical Implications of the Pharmacokinetics of Crizotinib in Populations of Patients with Non-Small Cell Lung Cancer
Erjian Wang et al.
CLINICAL CANCER RESEARCH (2016)
Population Pharmacokinetic/Pharmacodynamic Modeling of Sunitinib by Dosing Schedule in Patients with Advanced Renal Cell Carcinoma or Gastrointestinal Stromal Tumor
Reza Khosravan et al.
CLINICAL PHARMACOKINETICS (2016)
Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem
Timothy A. Roehrs et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2016)
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma
Leonid Gibiansky et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2016)
Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin
Mana Mitsuguro et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care
N. G. L. Jager et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Pharmacokinetics of single-agent axitinib across multiple solid tumor types
Michael A. Tortorici et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Gender Differences in Pharmacokinetics and Pharmacodynamics of Zolpidem Following Sublingual Administration
David J. Greenblatt et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Population Pharmacokinetics of Dabrafenib, a BRAF Inhibitor: Effect of Dose, Time, Covariates, and Relationship With Its Metabolites
Daniele Ouellet et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure-Response in CLL
E. Gibiansky et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
F. Mueller et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Understanding the Oral Mucosal Absorption and Resulting Clinical Pharmacokinetics of Asenapine
Jeremy A. Bartlett et al.
AAPS PHARMSCITECH (2012)
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL
Carsten Mueller et al.
BLOOD (2012)
Pharmacokinetics and Safety of Ezetimibe/Simvastatin Combination Tablet An Open-Label, Single-Dose Study in Healthy Chinese Subjects
Nan-Nan Chu et al.
CLINICAL DRUG INVESTIGATION (2012)
Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers
Yun Cai et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients
Tomohiro Sasaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A Pharmacokinetic Model for Evaluating the Impact of Hepatic and Intestinal First-Pass Loss of Saquinavir in the Rat
R. Lledo-Garcia et al.
DRUG METABOLISM AND DISPOSITION (2011)
Clinical Pharmacokinetics of Tonapofylline: Evaluation of Dose Proportionality, Oral Bioavailability, and Gender and Food Effects in Healthy Human Subjects
Zhaoyang Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch
C. Neill Epperson et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Sex Differences in Pharmacokinetics and Pharmacodynamics
Offie P. Soldin et al.
CLINICAL PHARMACOKINETICS (2009)
Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors
Peiming Ma et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
Jian-Feng Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Determinants of steady-state torasemide pharmacokinetics - Impact of pharmacogenetic factors, gender and angiotensin II receptor blockers
Dierk Werner et al.
CLINICAL PHARMACOKINETICS (2008)
Gender differences in the oral pharmacokinetics of Fluconazole
Miriam del C. Carrasco-Portugal et al.
CLINICAL DRUG INVESTIGATION (2007)
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin
Mikko Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine
Francesca T. Aweeka et al.
AIDS (2006)
Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats
Tatsuya Suzuki et al.
LIFE SCIENCES (2006)
Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK
P Jilma-Stohlawetz et al.
TRANSFUSION AND APHERESIS SCIENCE (2005)
The mechanism of action of methylprednisolone in the treatment of multiple sclerosis
JS Sloka et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
The effects of the 5-HT3 antagonist, alosetron, on brain serotonin synthesis in patients with irritable bowel syndrome
A Nakai et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
The influence of age and sex on the clearance of cytochrome P450 3A substrates
MM Cotreau et al.
CLINICAL PHARMACOKINETICS (2005)
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group study 359
CV Fletcher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir
SJ Mouly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1
MP Pai et al.
PHARMACOTHERAPY (2004)
In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: Studies using the rat single-pass intestinal perfusion model
CL Cummins et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke
K Kain et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Age and sex effects on the pharmacokinetics of linezolid
TL Sisson et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Sex and age differences in the pharmacokinetics of alosetron
KM Koch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers
DI Min et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Gender differences in labetalol kinetics: Importance of determining stereoisomer kinetics for racemic drugs
JA Johnson et al.
PHARMACOTHERAPY (2000)
Anti-seizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsy
CA Frye et al.
PSYCHONEUROENDOCRINOLOGY (2000)
分享论文
